Annexin V-CLIO: A nanoparticle for detecting apoptosis by MRI

Molecular Imaging

Volumn 1, Issue 2, 2002, Pages 102-107

  Schellenberger, Eyk A ^a   Bogdanov Jr , Alexei ^a   Högemann, Dagmar ^a   Tait, Jonathan ^b   Weissleder, Ralph ^a   Josephson, Lee ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Annexin V; Apoptosis; Iron oxide; MRI; Phosphatidylserine

Indexed keywords

CELLS; CROSSLINKING; IRON OXIDES; MIXTURES; NANOSTRUCTURED MATERIALS; PROTEINS;

APOPTOTIC CELLS;

MAGNETIC RESONANCE IMAGING;

CAMPTOTHECIN; CROSS LINKING REAGENT; FERRIC ION; FERRIC OXIDE; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CELL SURVIVAL; DRUG EFFECT; HUMAN; LEUKEMIA CELL LINE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; T CELL LYMPHOMA;

ANNEXIN A5; APOPTOSIS; CAMPTOTHECIN; CELL SURVIVAL; CROSS-LINKING REAGENTS; FERRIC COMPOUNDS; HUMANS; JURKAT CELLS; LYMPHOMA, T-CELL; MAGNETIC RESONANCE IMAGING;

EID: 0000425230     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535002320162769     Document Type: Article

References (26)

1. Blankenberg FG, Tait JF, Strauss HW (2000). Apoptotic cell death: Its implications for imaging in the next millennium. Eur J Nucl Med. 27:359-367.
2. Blankenberg FG, Strauss HW (2001). Will imaging of apoptosis play a role in clinical care? A tale of mice and men. Apoptosis. 6:117-123.
3. Blankenberg FG, Naumovski L, Tait JF, Post AM, Strauss HW (2001). Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V. J Nucl Med. 42:309-316.
4. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
5. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA (1994). Integrin alpha v beta 3 antagonists promote tumor regression by Inducing apoptosis of angiogenic blood vessels. Cell. 79:1157-1164.
6. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 182:1545-1556.
7. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW (1998). In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 95:6349-6354.
8. D'Arceuil H, Rhine W, de Crespigny A, Yenari M, Tait JF, Strauss WH, Engelhorn T, Kastrup A, Moseley M, Blankenberg FG (2000), 99mTc annexin V imaging of neonatal hypoxic brain injury. Stroke. 31:2692-2700.
9. Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA (2000). Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 356:209-212.
10. Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, Fitzpatrick JM, Raghunath PN, Tomaszewski JE, Kelly C, Steinmetz N, Green A, Tait JF, Leppo J, Blankenberg FG, Jain D, Strauss HW (2001). Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med. 7:1347-1352.
11. Högemann D, Ntziachristos V, Josephson L, Weissleder RW (2002). High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjug Chem. 13:116-122.
12. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM (2001). Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med. 7:1241-1244.
13. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989). Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR, Am J Roentgenol. 152:167-173.
14. Van Beers BE, Sempoux C, Materne R, Delos M, Smith AM (2001). Biodistribution of ultrasmall iron oxide particles in the rat liver. J Magn Reson Imaging. 13:594-599.
15. Majumdar S, Zoghbi SS, Gore JC (1990). Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat. Invest Radial. 25:771-777.
16. Wunderbaldinger P, Josephson L, Weissleder R (2002), Tat peptide directs enhanced clearance and hepatic permeability of magnetic neoparticles. Bioconjug Chem. 13:264-268.
17. Josephson L, Tung CH, Moore A, Weissleder R (1999). High-efficiency intracellular magnetic labeling with novel super-paramagnetic-Tat peptide conjugates. Bioconjug Chem. 10:186-191.
18. Josephson L, Perez JM, Weissleder R (2001). Magnetic nanosensors for the detection of oligonucleotide sequences. Agnew Chem Int Ed. 40:3204-3206.
19. Hogemann D, Josephson L, Weissleder R, Basilion JP (2000). Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem. 11:941-946.
20. Kang HW, Josephson L, Petrovsky A, Weissleder R, Bogdanov AJ (2002). Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem. 13:122-127.
21. Shen T, Weissleder R, Papisov M, Bogdanov A Jr., Brady TJ (1993). Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties. Magn Reson Med. 29:599-604.
22. Wood BL, Gibson DF, Tait JF (1996). Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flowcytometric measurement and clinical associations. Blood. 88:1873-1880.
23. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
24. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K (1987). Human placental anticoagulant protein: Isolation and characterization. Biochemistry. 26:5572-5578.
25. Tait JF, Engelhardt S, Smith C, Fujikawa K (1995). Prourokinaseannexin V chimeras. Construction, expression, and characterization of recombinant proteins. J Biol Chem. 270:21594-21599.
26. Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW (2000). Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. Bioconjug Chem. 11:918-925.